CL
AXDX

CSS LLC’s Accelerate Diagnostics AXDX Stock Holding History

CSS LLC’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,610
Closed -$25.5K – 735
2022
Q4 		$25.5K Hold
3,610
– – ﹤0.01% 768
2022
Q3 		$55K Hold
3,610
– – ﹤0.01% 875
2022
Q2 		$36K Hold
3,610
– – ﹤0.01% 967
2022
Q1 		$52K Hold
3,610
– – ﹤0.01% 1001
2021
Q4 		$188K Hold
3,610
– – 0.01% 914
2021
Q3 		$210K Hold
3,610
– – 0.01% 865
2021
Q2 		$291K Hold
3,610
– – 0.01% 768
2021
Q1 		$300K Hold
3,610
– – 0.01% 678
2020
Q4 		$274K Hold
3,610
– – 0.01% 581
2020
Q3 		$385K Buy
3,610
+20
+0.6% +$2.78K 0.02% 464
2020
Q2 		$544K Buy
3,590
+1,190
+50% +$117K 0.03% 370
2020
Q1 		$200K Buy
2,400
+444
+23% +$62.5K 0.02% 426
2019
Q4 		$331K Buy
+1,956
New +$323K 0.02% 418

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return

CSS LLC's AXDX Position: Q1 2023 in Review

CSS LLC sold out of Accelerate Diagnostics (AXDX) in Q1 2023, closing a stake of 3,610 shares — an estimated $25.5K sold.

CSS LLC first reported a position in AXDX in Q4 2019 and held it in 13 quarters. The position peaked at $544K in Q2 2020. 67 funds tracked by Wall St. Rank hold AXDX as of Q1 2023.

  • CSS LLC reported no remaining Accelerate Diagnostics position as of Q1 2023 after selling out during the quarter.
  • CSS LLC sold 3,610 Accelerate Diagnostics shares in Q1 2023, an estimated $25.5K.
  • CSS LLC first reported a position in Accelerate Diagnostics in Q4 2019 and held it in 13 quarters.
  • CSS LLC's Accelerate Diagnostics position peaked at $544K in Q2 2020.
  • 67 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2023.

Based on CSS LLC's 13F filing for Q1 2023, filed 15 May 2023.